U.S. to Increase Production of the Ebola Drug ZMapp, but May Not Meet Demand by ANDREW POLLACK

By ANDREW POLLACK

Despite the new efforts, supplies of the drug, ZMapp, are expected to be limited to hundreds or thousands of treatment courses by early next year, which would not be nearly enough if the epidemic continues to spiral out of control.

Published: October 2, 2014 at 12:00AM

from WordPress http://ift.tt/1xEnzAT